WorldPharmaNews
  • Home
  • Business
  • Research
  • Events
  • Regulatory

Bristol-Myers Squibb

Bristol-Myers SquibbBristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

www.bms.com.

Bristol-Myers Squibb RSS Channel

Filters
List of articles in category Bristol-Myers Squibb
Title Published Date
Bristol-Myers Squibb announces new collaboration to evaluate combination therapy in colorectal cancer 05 June 2017
Array BioPharma and Bristol-Myers Squibb announce strategic collaboration 30 May 2017
Bristol-Myers Squibb enters into separate agreements with Biogen and Roche to License anti-eTau and anti-myostatin compounds 13 April 2017
The first overall survival data from the Phase 3 CheckMate -067 clinical trial 03 April 2017
Parker Institute for Cancer Immunotherapy, Bristol-Myers Squibb and the Cancer Research Institute announce collaboration to accelerate immuno-oncology research 28 March 2017
Bristol-Myers Squibb expands focus on precision medicine with investment and planned collaboration with GRAIL 02 March 2017
Bristol-Myers Squibb expands International Immuno-Oncology Network (II-ON) 27 February 2017
Bristol-Myers Squibb appoints three new independent directors 21 February 2017
Bristol-Myers Squibb reports fourth quarter and full year 2016 financial results 26 January 2017
Bristol-Myers Squibb and GeneCentric Diagnostics announce exploratory biomarker research collaboration 10 January 2017
Bristol-Myers Squibb announces immunotherapy clinical collaboration with Janssen 05 January 2017
Bristol-Myers Squibb signs exclusive worldwide license agreement with PsiOxus Therapeutics 20 December 2016
Bristol-Myers Squibb strengthens capabilities with evolution of its U.S. geographic footprint 13 December 2016
Bristol-Myers Squibb reports third quarter results 27 October 2016
Bristol-Myers Squibb Foundation joins White House Cancer Moonshot 18 October 2016
Bristol-Myers Squibb and Nektar Therapeutics announce oncology clinical collaboration to evaluate the combination of Opdivo (nivolumab) and NKTR-214 27 September 2016
Bristol-Myers Squibb awards first "Golden Tickets" for LabCentral to PanTher, Suono Bio 20 September 2016
Bristol-Myers Squibb employees cycle Coast to Coast to raise money and awareness for cancer research 07 September 2016
Bristol-Myers Squibb reports second quarter financial results 29 July 2016
Bristol-Myers Squibb acquires Cormorant Pharmaceuticals 05 July 2016
  • Start
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next
  • End

Business & Industry

  • GSK completes acquisition of Sierra Oncology
  • Pfizer and BioNTech announce new agreement with U.S. government to provide additional doses of COVID-19 vaccine
  • Bayer opens new Research & Innovation Center in Boston-Cambridge demonstrating its commitment to precision oncology
  • New Novartis extension phase data show nearly 80% of RMS patients treated with Kesimpta® (ofatumumab) had no evidence of disease activity (NEDA-3)
  • Pfizer and BioNTech announce Omicron-adapted COVID-19 vaccine candidates demonstrate high immune response against Omicron

Research & Development

  • Researchers discover new leukemia-killing compounds
  • Oral antiviral drug effective against respiratory syncytial virus (RSV) identified by researchers
  • Biomarkers found that could be drug targets against a deadly form of brain cancer
  • COVID-19 rebound after taking Paxlovid likely due to insufficient drug exposure
  • Novel drug combo activates natural killer cell immunity to destroy cancer cells
  • Broadly neutralizing antibodies could provide immunity against SARS-CoV-2 variants
  • A new technology offers treatment for HIV infection through a single injection

Conferences & Events

  • New approach to treatment of deadly kidney cancer
  • SAE Media Group proudly presents the 2nd Annual Aseptic Processing Conference
  • Pharma join together to achieve new standards in digital and patient innovation for clinical transformation
  • SMi's 22nd Annual Pain Therapeutics Conference
  • SMi Group Introduces the 4th Annual Injectable Drug Delivery Conference 2022
  • SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference
  • SMi's 3rd Annual AI in Drug Discovery Conference

Regulatory Affairs

  • FDA approves first systemic treatment for alopecia areata
  • FDA urges drug manufacturers to develop risk management plans to promote a dtronger, resilient drug supply chain
  • FDA limits use of Janssen COVID-19 vaccine to certain individuals
  • EMA establishes Cancer Medicines Forum with academia to optimise cancer treatments in clinical practice
  • FDA approves first generic of Symbicort to treat asthma and COPD
  1. You are here:  
  2. Home
  3. Bristol-Myers Squibb

About

  • Home
  • Advertise
  • Privacy
  • Cookie Preferences
  • Terms of Use
  • Contact

Top News Channels

  • Industry
  • Research
  • Regulatory

Submit Your News!

Follow / Join us

Didn't we got you connected? If not, please note the following magic buttons:
  • Facebook
  • Twitter
  • LinkedIn
  • XING
  • RSS

Digest World Pharma Newsletter

Subscribe to our weekly Digest Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

© World Pharma News 2022. All Rights Reserved.